Arcinova and Charles River Collaboration Info Sheet

Our strategic collaboration with Charles River offers customers unique integrated programmes that bridge molecules from early discovery to proof of concept (POC) and beyond. This removes obstacles from the critical path, reduces development risks, eliminates the white space in preclinical drug development and accelerates the pathway to clinical development. 

The overlap between Charles River and Arcinova capabilities provide flexibility for customers, dedicated project teams, and a bespoke service that is tailored to each development programme.